Porth R, Deyhim T, Geeganage G, Smith B, et al. Proactive Therapeutic Drug Monitoring of Ustekinumab Is Associated With Increased Drug Persistence in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis 2024 Sep 26:izae231. doi: 10.1093.
PMID: 39326011